Trademark Overview
On Friday, May 5, 2023, a trademark application was filed for ENDOSIGN with the United States Patent and Trademark Office. The USPTO has given the ENDOSIGN trademark a serial number of 79371841. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 24, 2024. This trademark is owned by Cyted Ltd. The ENDOSIGN trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable and recorded computer software for cancer and gastrointestinal disease screening and diagnostic purposes in the medical field; downloadable and recorded computer software for use in patient treatment medical decision support systems; downloadable and recorded artificial intelligence software for cancer and gastrointestinal disease screening and diagnostic healthcare; downloadable and recorded machine learning software for analysis; downloadable and recorded machine learning software for healthcare; downloadable and recorded software for operational management for medical devices device (SaMD); downloadable electronic publications in the fields of medical and medical diagnostic assessment.
Medical services; medical diagnostic services; medical testing; medical advisory services; medical treatment of cancer and gastrointestinal disease services; medical and healthcare clinics; providing medical information regarding testing and diagnosis of diseases and infections; providing medical information regarding diagnosis and treatment of diseases and infections.
Medical apparatus and instruments for diagnostic and medical use; medical apparatus and instruments namely tissue collection apparatus and tissue analysis apparatus; diagnostic imaging apparatus for medical use; diagnostic testing apparatus in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing for medical use.
Medical research services; pharmacological medical research services; medical research laboratory services; software as a service [SaaS] services featuring software for identifying markers for screening and diagnostic purposes for cancer and gastrointestinal disease; software creation; custom software development services; platform as a service (PAAS) featuring artificial intelligence computer software platforms for diagnosing cancer and gastrointestinal disease; computer aided pathological diagnostic testing services for diagnostic and treatment purposes; design and development of computer software; design and development of medical technology; design and development of computer software for use with medical technology; design and development of medical diagnostic apparatus; biomedical research services; electronic storage of medical records; calibration services for medical apparatus; providing scientific information in the field of medical disorders and their treatment.
